Tag: #Global Trends

Key Development Competition in the obesity and diabetes market has entered a new phase where legal strategy is becoming as... Read more

Key Development NHS England has officially issued routine commissioning approvals for two specialized rare blood cancer therapies: Novartis’ Tafinlar® (dabrafenib)... Read more

Key Development Samsung Biologics has announced an all-cash acquisition offer valued at approximately CHF 1.46 billion (US$1.8 billion) for Swiss-based... Read more

Key Development Novartis is entering one of the most consequential periods in its post-transformation strategy. While the company continues to... Read more

Key Development Merck has announced that Keytruda (pembrolizumab) became the first PD-1 inhibitor to demonstrate a clinically meaningful benefit as... Read more

Key Development The Oncology Institute (NASDAQ: TOI) disclosed that its Chief Medical Officer (CMO), Dr. Yale D. Podnos, sold company... Read more

Key Development Voyager Technologies has signed a memorandum of understanding (MOU) with Geisinger, one of the largest integrated health systems... Read more

Key Development A recent poisoning incident involving an elderly patient has drawn attention to a much larger issue than a... Read more

Key Development Brazilian retailer Assaí Atacadista has expanded into the pharmacy business, opening its first in-store pharmacy in the state... Read more